Rebalix
Invesco · sheet of 20 October 2026
Invesco · sheet of 20 October 2026ETF sheet · official issuer and register data
Invesco Global Active ESG Equity UCITS ETF EUR PfHdg Dist
IQSD · IE0008YN55P8 · class EUR PfHdg Dist · EUR · domicile Ireland
Equity · GlobalactiveEUR-hedged share classSFDR art. 8
Comparison benchmark: MSCI World Total Return (Net) Index
- TER
- 0.30%+ trans. 0.10%
- Fund size
- 2.8 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Activeactive management
- Income
- Distributingquarterly
Launch 7 Sept 2022 · costs from the KID as of 2 Oct 2026 · 204 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to achieve a long-term return in excess of the MSCI World Index (the "Benchmark"), by investing in an actively managed portfolio of global equities that meets a defined set of environmental, social, and corporate governance criteria (the "ESG Criteria"). Investment approach: To achieve the investment objective, the Fund invests in shares of companies from developed markets worldwide. Eligible stocks are screened for compliance with the Fund’s ESG Criteria, which incorporates both exclusion criteria…
Performance since series start (in euro) — base 100
7 Sept 2022 → 15 Oct 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +21.7% |
| 3 years | +88.3% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +111.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.06% | 12.80% | — |
| Max drawdown | −8.86% | −17.16% | — |
| Sharpe | 1.28 | 1.29 | — |
| Sortino | 1.94 | 1.85 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IQSD · IE0008YN55P81
RebalixIQSD · IE0008YN55P8 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication
Distributions · per share, in EUR
Frequency: quarterly · last 12 months: 0.9615 EUR (1.22% of NAV) · last ex-date 10 Sept 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.7673 | — |
| 2025 | 4 | 0.8041 | +1.35% |
| 2024 | 4 | 0.972 | +1.99% |
| 2023 | 4 | 0.8503 | +2.09% |
| 2022 | 1 | 0.1403 | — |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Oct 2026 · 204 securities · top-10 weight = 25.0%
| Top holdings | Weight |
|---|---|
| 6.4% | |
| 4.6% | |
| 3.6% | |
| 1.8% | |
| 1.7% | |
| 1.4% | |
| 1.4% | |
| 1.4% | |
| 1.4% | |
| 1.4% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
IQSD · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 4 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE0008YN55P8
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE0008YN55P8
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IQSD · IE0008YN55P82